Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Killock

Showing results (51-60 of 304) with videos related to

Pageof 31
Sort By:
Nature Reviews. Clinical Oncology|May 5, 2016
Immunotherapy: Overcoming checkpoints in Merkel-cell carcinomaDavid Killock
Nature Reviews. Clinical Oncology|June 24, 2022
SHINE a light: frontline ibrutinib for MCLDavid Killock
Nature Reviews. Clinical Oncology|September 19, 2020
Biomarkers 101 - personalizing therapy for RCCDavid Killock
Nature Reviews. Urology|September 24, 2020
Biomarkers 101 - personalizing therapy for RCCDavid Killock
Nature Reviews. Clinical Oncology|June 21, 2024
NICHE-2 validates the efficacy of neoadjuvant ICIs in dMMR colon cancerDavid Killock
Nature Reviews. Clinical Oncology|February 22, 2020
Extent of resection is important across glioblastoma molecular subtypesDavid Killock
Nature Reviews. Clinical Oncology|June 17, 2025
Adding durvalumab to perioperative FLOT improves gastric cancer outcomesDavid Killock
Nature Reviews. Clinical Oncology|February 6, 2021
WEE1 inhibition after platinum resistanceDavid Killock
Nature Reviews. Clinical Oncology|November 3, 2016
Lung cancer: Anti-PD-1 therapy in the frontlineDavid Killock
Nature Reviews. Clinical Oncology|November 10, 2018
New window of opportunity with ICIs in melanomaDavid Killock
Pageof 31

Showing results (51-60 of 304) with videos related to

Sort By:
Pageof 31
Nature Reviews. Clinical Oncology|May 5, 2016
Immunotherapy: Overcoming checkpoints in Merkel-cell carcinomaDavid Killock
Nature Reviews. Clinical Oncology|June 24, 2022
SHINE a light: frontline ibrutinib for MCLDavid Killock
Nature Reviews. Clinical Oncology|September 19, 2020
Biomarkers 101 - personalizing therapy for RCCDavid Killock
Nature Reviews. Urology|September 24, 2020
Biomarkers 101 - personalizing therapy for RCCDavid Killock
Nature Reviews. Clinical Oncology|June 21, 2024
NICHE-2 validates the efficacy of neoadjuvant ICIs in dMMR colon cancerDavid Killock
Nature Reviews. Clinical Oncology|February 22, 2020
Extent of resection is important across glioblastoma molecular subtypesDavid Killock
Nature Reviews. Clinical Oncology|June 17, 2025
Adding durvalumab to perioperative FLOT improves gastric cancer outcomesDavid Killock
Nature Reviews. Clinical Oncology|February 6, 2021
WEE1 inhibition after platinum resistanceDavid Killock
Nature Reviews. Clinical Oncology|November 3, 2016
Lung cancer: Anti-PD-1 therapy in the frontlineDavid Killock
Nature Reviews. Clinical Oncology|November 10, 2018
New window of opportunity with ICIs in melanomaDavid Killock
Pageof 31